Elekta (OTCMKTS:EKTAY) Stock Price Up 14.1% – Time to Buy?

Elekta AB (OTCMKTS:EKTAY) shares traded up 14.1% during mid-day trading on Friday . The company traded as high as $6.6910 and last traded at $6.6910. 370 shares changed hands during trading, a decline of 87% from the average session volume of 2,746 shares. The stock had previously closed at $5.8650.

Elekta Stock Performance

The stock has a market cap of $2.47 billion, a PE ratio of 95.60 and a beta of 1.07. The firm’s 50-day moving average is $6.29 and its 200 day moving average is $5.58. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 1.04.

Elekta (OTCMKTS:EKTAY) last announced its earnings results on Thursday, March 5th. The company reported $0.09 EPS for the quarter. Elekta had a net margin of 1.62% and a return on equity of 12.14%. The business had revenue of $433.29 million during the quarter. As a group, research analysts anticipate that Elekta AB will post 0.36 EPS for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.